OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019; Pre-Conference Webcast Available March 11
04 März 2019 - 2:31PM
OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging
platform for the pharmaceutical industry, has been invited to
present at the 31st Annual ROTH Conference being held at The Ritz
Carlton, Laguna Niguel in Orange County, California, on March
17-19, 2019.
The conference will feature presentations from public and
private companies across a variety of industry sectors. Last year,
the ROTH Conference hosted close to 550 participating companies and
more than 4,700 attendees, including institutional investors,
analysts, family offices and high net worth investors.
OptimizeRx CEO, Will Febbo, is scheduled to present in
one-on-one meetings with institutional analysts and investors held
throughout the day on March 18-19. He will discuss a number of
topics, including the company’s record results for the fourth
quarter of 2018, the acquisition of CareSpeak Communications, and
growth of the company’s digital health platform. The network has
become the largest of its kind, now reaching more than half of the
ambulatory patient market in the U.S.
The company recently reported its seventh sequential quarter of
revenue growth, driving 2018 revenue up 75% to a record $21.2
million and the company’s first year of profitability. The company
plans to maintain a gross margin target of at least 55% in 2019, as
new digital health messaging pharma clients and programs ramp
up.
ROTH will host a pre-recorded webcast of the company’s
presentation, which will be available on the conference website
here and in the investor section of the company’s website under
“Event Calendar,” beginning on March 11.
OptimizeRx management is scheduled to participate in a panel,
“Enterprise Messaging Trends & Strategies” at 11:00 a.m.
Pacific time on Tuesday, March 19. The company will co-host the
panel with LivePerson, a leading provider of conversational
commerce solutions.
To schedule a one-on-one meeting with OptimizeRx, please contact
your ROTH representative. For any questions about the company,
contact Ron Both of CMA at (949) 432-7557 or submit your request
here.
About Roth Capital PartnersROTH Capital
Partners, LLC (ROTH), is a relationship-driven investment bank
focused on serving emerging growth companies and their investors.
As a full-service investment bank, ROTH provides capital raising,
M&A advisory, analytical research, trading, market-making
services and corporate access. Headquartered in Newport Beach, CA,
ROTH is privately-held and employee owned, and maintains offices
throughout the U.S. For more information on ROTH, please
visit www.roth.com.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies
to patients and providers, offering greater affordability,
adherence and brand awareness at the point-of-care. As the nation’s
largest point-of-prescribe promotional platform for the
pharmaceutical industry, OptimizeRx provides a direct
channel for pharma companies to communicate with healthcare
providers right within their workflow and also directly to
patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half
of the ambulatory patient market with access to these benefits
through leading EHR platforms like Allscripts, Amazing Charts and
Quest, and directly via its mobile communications
platform.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking,' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
Media Relations ContactNicole Brooks, Innsena
CommunicationsTel (860) 800-2344nicolebrooks@innsena.com
Investor Relations ContactRon Both, CMATel
(949) 432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024